Joon Lee
Stock Analyst at Truist Securities
(4.85)
# 68
Out of 5,182 analysts
116
Total ratings
65.22%
Success rate
49.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $490 → $525 | $440.05 | +19.30% | 5 | Mar 11, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $500 → $700 | $317.00 | +120.82% | 8 | Feb 20, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $195.31 | +17.76% | 4 | Jan 12, 2026 | |
| ARGX argenx SE | Maintains: Buy | $950 → $1,030 | $809.27 | +27.28% | 14 | Jan 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $54.88 | +82.22% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $7.26 | +588.71% | 4 | Dec 15, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $33.75 | +62.96% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $14.26 | -1.82% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $23.63 | +280.87% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $34.65 | +26.98% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $86 | $70.42 | +22.12% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $35.01 | +114.22% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $10.58 | +98.49% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $43.30 | +246.42% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $178.33 | +12.15% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $54.83 | +118.86% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.86 | +270.37% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.39 | +90.70% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $25.34 | +42.07% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.20 | +150.00% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $7.32 | +132.24% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.42 | +13.12% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.84 | +368.75% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.89 | +9,588.58% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $68.73 | -50.53% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Mar 11, 2026
Maintains: Buy
Price Target: $490 → $525
Current: $440.05
Upside: +19.30%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Buy
Price Target: $500 → $700
Current: $317.00
Upside: +120.82%
Jazz Pharmaceuticals
Jan 12, 2026
Maintains: Buy
Price Target: $220 → $230
Current: $195.31
Upside: +17.76%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $950 → $1,030
Current: $809.27
Upside: +27.28%
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $54.88
Upside: +82.22%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $7.26
Upside: +588.71%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $33.75
Upside: +62.96%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $14.26
Upside: -1.82%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $23.63
Upside: +280.87%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $34.65
Upside: +26.98%
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $70.42
Upside: +22.12%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $35.01
Upside: +114.22%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $10.58
Upside: +98.49%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $43.30
Upside: +246.42%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $178.33
Upside: +12.15%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $54.83
Upside: +118.86%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $4.86
Upside: +270.37%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $8.39
Upside: +90.70%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $25.34
Upside: +42.07%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $3.20
Upside: +150.00%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.32
Upside: +132.24%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.42
Upside: +13.12%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.84
Upside: +368.75%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.89
Upside: +9,588.58%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $68.73
Upside: -50.53%